Stay updated on CMP-001 Combo With Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page.

Latest updates to the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check55 days agoChange DetectedFooter revision label updated to v3.5.0, replacing the previous v3.4.3 label.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision label on the page footer updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedSystem update: Revision to v3.4.2 has been applied. No changes to the study content or layout are observed, and prior funding-status notices have been removed.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a government funding–lapse notice noting the NIH Clinical Center is open and that operating status information is available at opm.gov, and updated the site version to v3.4.1 (removing v3.4.0).SummaryDifference0.4%

Stay in the know with updates to CMP-001 Combo With Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page.